X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Newly Identified Biomarker Linked to Metastatic Prostate Cancer Development

Researchers from Rutgers University have identified human gene markers that lead to the development of metastatic prostate cancer or cancer that spreads past the prostate.

Prostate cancer is the second leading cause of cancer-related death in men in the United States, and metastatic prostate cancer has a five-year survival rate of 30%.

Read the full article here. 

source: Rebecca Arajuo - DocWire News